Clinical trial

A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC

NCT03987087

Study summary

ClinicalTrials.gov

A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention Radiation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-09-01

PhasePHASE2

Conditions

Malignant Pleural Effusionunresolved

Nonsmall Cell Lung Cancer, Stage IVunresolved

Interventions

RadiationRADIATION

ChemotherapyDRUG

Sponsors & collaborators

Guizhou Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03987087 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.